Invention Grant
- Patent Title: Biheterocyclic compound
-
Application No.: US17079761Application Date: 2020-10-26
-
Publication No.: US11440905B2Publication Date: 2022-09-13
- Inventor: Hitoshi Watanabe , Yoshiaki Isobe , Hidenori Kimura , Yuji Fujiwara
- Applicant: SUMITOMO PHARMA CO., LTD.
- Applicant Address: JP Osaka
- Assignee: SUMITOMO PHARMA CO., LTD.
- Current Assignee: SUMITOMO PHARMA CO., LTD.
- Current Assignee Address: JP Osaka
- Agency: Sughrue Mion, PLLC
- Priority: JP2016-006205 20160115,JP2016-173510 20160906
- Main IPC: C07D405/14
- IPC: C07D405/14 ; A61K31/352 ; A61K31/4192 ; A61K31/4709 ; A61K31/519 ; C07D311/22 ; C07D405/04 ; C07D471/04 ; A61P25/28 ; A61P27/04

Abstract:
The present invention provides a compound of formula (1) and a pharmaceutical composition comprising the compound useful as a nerve regeneration promoter wherein R1-L- is R1—OC(O)—, or the like, R1 is hydrogen atom, optionally-substituted C1-6 alkyl group, optionally-substituted 3- to 8-membered cycloalkyl group, or the like, R2 is hydrogen atom or the like, Ring A is formula (2) or formula (3) wherein R3 is hydrogen atom, optionally-substituted C1-6 alkyl group, or the like, the part of X, Y, and Z is X═Y—Z, X—Y═Z, or X—Y—Z, X is nitrogen atom, NR4 (R4 is hydrogen atom, optionally-substituted C1-6 alkyl group, or the like), or the like, Y is carbon atom or the like, and Z is carbon atom, nitrogen atom or the like.
Public/Granted literature
- US20210198242A1 BIHETEROCYCLIC COMPOUND Public/Granted day:2021-07-01
Information query